Find uplifting stories about heroes, innovations, and solutions
1194 results for "brca gene"
Scientists have begun testing a breakthrough gene therapy that could restore hearing for people with the most common genetic cause of deafness. Skylark Bio just dosed their first patient, marking a major step toward helping millions born with this genetic mutation.
The NHS is creating the world's first national database of 120 cancer-linked genes, offering free genetic testing and early screening to tens of thousands of families. It's a game-changing shift from treating cancer to preventing it before it starts.
Melbourne researchers developed an AI tool that creates molecular "off switches" for CRISPR gene editing in just 8 weeks. The breakthrough could help make gene therapy treatments safer and more accessible for patients with genetic diseases.
Australian researchers developed an AI system that makes gene editing safer by protecting healthy genes during treatment. The breakthrough could transform how doctors treat genetic diseases like cystic fibrosis.
Children born completely deaf are hearing whispers for the first time thanks to an experimental gene therapy that has shown remarkable success in the largest study of its kind. The treatment could become the first FDA-approved gene therapy for deafness within months.
After decades of skepticism, researchers have perfected a gentler way to control genes using epigenetic editing. This breakthrough lets them dial gene expression up or down without changing DNA itself, opening doors to safer treatments and smarter crops.
Scientists used AlphaFold AI to redesign gene-editing proteins, making them dramatically safer by nearly eliminating unwanted DNA changes. This breakthrough could help life-saving gene therapies reach more patients with fewer risks.
Scientists built an AI that designs synthetic DNA switches capable of turning genes on and off in specific cells, potentially transforming how we treat diseases like leukemia. In lab tests, these AI-generated sequences actually outperformed natural DNA at reactivating a protective gene in leukemia cells.
A groundbreaking gene therapy trial has achieved what doctors call a "functional cure" for sickle cell disease, eliminating painful crises in 27 out of 28 patients. The one-time treatment uses gene editing to fix the blood disorder that has killed patients decades too soon.
Scientists have developed a new gene editing approach that spreads healing changes from cell to cell, dramatically increasing its reach in the body. This breakthrough could transform treatment for countless genetic diseases that were previously too difficult to address.
Serenity Cole, 18, spent years in constant pain from sickle cell disease. Now she's pain-free thanks to a revolutionary payment deal where drug companies only get paid if their $2-3 million gene therapies actually work.
Scientists tested a one-time gene therapy that lowered cholesterol up to 62% in patients, potentially replacing daily pills and injections with a single treatment. The breakthrough could transform how millions manage heart disease risk.
University of Virginia researchers used gene editing to fix the DNA mutation causing a deadly form of epilepsy, potentially opening the door to cures for inherited brain disorders. The technique eliminated seizures in lab mice and improved their movement and cognitive function.
Scientists have successfully used gene editing to restore vision in a mouse model of a hereditary disease that causes blindness in young people. The breakthrough offers hope for thousands living with an incurable condition.
Scientists are developing a breakthrough gene editing approach that spreads between cells like neighbors sharing flyers. This could treat far more diseases by reaching dramatically more cells in the body.
Scientists have created a precise gene-editing tool that could offer permanent treatment for cystic fibrosis patients, potentially replacing daily medications that cost hundreds of thousands of dollars per year. The breakthrough could transform care for people living with this and other genetic diseases.
A 21-year-old bioengineering student diagnosed with a rare muscle disease at 13 is now engineering a potential cure for herself and nearly 1 million others worldwide. Héloïse Hoffmann just won a $100,000 fellowship to advance her groundbreaking gene therapy research.
Israeli researchers used CRISPR technology to remove the gene that makes grapefruit taste bitter, potentially opening the door for kids and picky eaters to enjoy this nutritious fruit. The breakthrough could expand the market for grapefruit and help more people access its health benefits without the pucker.
A groundbreaking partnership between Canadian and Japanese biotech companies could slash the cost of life-saving gene therapies. With government support, they're creating technology to produce treatments faster and cheaper than ever before. --- ##
Researchers who developed the first FDA-approved gene therapy for inherited blindness are among this year's $3 million Breakthrough Prize winners. Their work is opening doors for treatments that were once considered impossible.
Showing 20 of 1194